Literature DB >> 17015282

Effect of polyphenolic extract, Pycnogenol, on the level of 8-oxoguanine in children suffering from attention deficit/hyperactivity disorder.

Zuzana Chovanová1, Jana Muchová, Monika Sivonová, Monika Dvoráková, Ingrid Zitnanová, Iveta Waczulíková, Jana Trebatická, Igor Skodácek, Zdenka Duracková.   

Abstract

The purpose of this randomized, double-blind and placebo controlled study was to test the effect of polyphenolic extract of pine bark Pycnogenol (Pyc) on the level of oxidized purines represented by 8-oxo-7,8-dihydroguanine (8-oxoG) and on the total antioxidant status (TAS) in children with attention deficit/hyperactivity disorder (ADHD).We have found significantly increased damage to DNA in ADHD children when compared to controls. 8-oxoG was significantly lower after 1 month of Pyc administration in comparison to the beginning state and to placebo group. TAS in ADHD children was lower in comparison to controls. After Pyc administration, TAS was elevated but statistically significant increase was recorded after 1 month of termination of Pyc application. Improvement of DNA damage and TAS after Pyc administration is associated with the improvement of attention in ADHD children. In conclusion, Pycnogenol(R) administration reduces oxidative damage to DNA, normalizes TAS and improves attention of ADHD children. Explanation of mutual relation between oxidative damage to DNA, TAS and symptoms of ADHD and mechanism of Pyc's action needs further investigations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17015282     DOI: 10.1080/10715760600824902

Source DB:  PubMed          Journal:  Free Radic Res        ISSN: 1029-2470


  18 in total

1.  Impact of psychostimulants and atomoxetine on the expression of 8-hydroxyguanine glycosylase 1 in human cells.

Authors:  Andreas Johannes Schmidt; Hans-Willi Clement; Stefan Gebhardt; Ulrich Michael Hemmeter; Eberhard Schulz; Jürgen-Christian Krieg; Tilo Kircher; Philip Heiser
Journal:  J Neural Transm (Vienna)       Date:  2010-05-14       Impact factor: 3.575

Review 2.  Biomarkers in the diagnosis of ADHD--promising directions.

Authors:  Stephen V Faraone; Cristian Bonvicini; Catia Scassellati
Journal:  Curr Psychiatry Rep       Date:  2014-11       Impact factor: 5.285

3.  Oxidative stress and immune aberrancies in attention-deficit/hyperactivity disorder (ADHD): a case-control comparison.

Authors:  Annelies A J Verlaet; Annelies Breynaert; Berten Ceulemans; Tess De Bruyne; Erik Fransen; Luc Pieters; Huub F J Savelkoul; Nina Hermans
Journal:  Eur Child Adolesc Psychiatry       Date:  2018-10-22       Impact factor: 4.785

4.  Oxidative Stress and ADHD: A Meta-Analysis.

Authors:  Nidhin Joseph; Yanli Zhang-James; Andras Perl; Stephen V Faraone
Journal:  J Atten Disord       Date:  2013-11-14       Impact factor: 3.256

5.  The effect of antioxidant supplementation on fatigue during exercise: potential role for NAD+(H).

Authors:  John Mach; Adrian W Midgley; Steve Dank; Ross S Grant; David J Bentley
Journal:  Nutrients       Date:  2010-03-10       Impact factor: 5.717

6.  Pharmaceutical and nutraceutical effects of Pinus pinaster bark extract.

Authors:  S Iravani; B Zolfaghari
Journal:  Res Pharm Sci       Date:  2011-01

7.  Maternal P7C3-A20 Treatment Protects Offspring from Neuropsychiatric Sequelae of Prenatal Stress.

Authors:  Rachel Schroeder; Preethy Sridharan; Lynn Nguyen; Alexandra Loren; Noelle S Williams; Kavitha P Kettimuthu; Coral J Cintrón-Pérez; Edwin Vázquez-Rosa; Andrew A Pieper; Hanna E Stevens
Journal:  Antioxid Redox Signal       Date:  2021-01-29       Impact factor: 7.468

Review 8.  Psychiatric Disorders and Polyphenols: Can They Be Helpful in Therapy?

Authors:  Jana Trebatická; Zdeňka Ďuračková
Journal:  Oxid Med Cell Longev       Date:  2015-06-09       Impact factor: 6.543

9.  Decreased Serum Cu/Zn SOD Associated with High Copper in Children with Attention Deficit Hyperactivity Disorder (ADHD).

Authors:  A J Russo
Journal:  J Cent Nerv Syst Dis       Date:  2010-05-04

10.  Pine bark (Pinus spp.) extract for treating chronic disorders.

Authors:  Nina U Robertson; Anel Schoonees; Amanda Brand; Janicke Visser
Journal:  Cochrane Database Syst Rev       Date:  2020-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.